MedTrace Logo

Discovery of New Early Detection Biomarkers From Peripheral Blood of Acute Respiratory Distress Syndrome(ARDS)

NCT02967471 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2016-11-21

No results posted yet for this study

Summary

Acute respiratory distress syndrome (ARDS) has a very poor prognosis and high mortality. To improve the early diagnosis of ARDS, there is an urgent need for novel biomarkers of ARDS. This project aims to detect novel biomarkers from peripheral blood , which can improve the early diagnosis and develop a more efficient therapy to enhance ARDS patient survival rate. Clinical data and blood sample were recorded before treatment and after treatment. Acute Physiology And Chronic Health Evaluation III (APACHE III) scores were calculated at enrolment. Different kinds of lymphocytes from blood samples would be detected by flow cytometry ,which could be used for discovering high sensitivity and specificity ARDS biomarker.

Conditions

  • Acute Respiratory Distress Syndrome

Sponsors & Collaborators

  • The Third Affiliated Hospital of Southern Medical University

    lead OTHER_GOV

Principal Investigators

  • Jinhong Wang, M.D. · The Third Affiliated Hospital of Southern Medical University

  • Hui Peng, M.M. · The Third Affiliated Hospital of Southern Medical University

  • Hong Yang, M.D. · The Third Affiliated Hospital of Southern Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-31
Primary Completion
2018-10-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02967471 on ClinicalTrials.gov